Virtual Reality–Based Vision Therapy for Intermittent Exotropia
JAMA Network Open · 09.03.2026 · 9 (3) · e260631
DOI: 10.1001/jamanetworkopen.2026.0631 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, online erschienen am 09.03.2026. Verfasst von Yu Jing und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Exotropia, Virtual Reality, Virtual Reality Exposure Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Intermittent exotropia (IXT), the most common childhood divergent strabismus, disrupts binocular vision and psychosocial function.
Objective
To assess the efficacy and safety of virtual reality–based vision therapy (VRVT) in children with IXT. Design, Setting, and Participants This randomized clinical trial consists of a 12-week treatment phase (completed) and a 12-month follow-up phase (ongoing). The treatment phase was conducted from July 1, 2023, to November 17, 2024, in 3 tertiary hospitals in China. Eligible participants were children aged 6 to 18 years with previously untreated IXT, an exodeviation magnitude of 10 to 30 prism diopters at distance, an exotropia control score of 1 to 3 at both distance and near, and a cycloplegic spherical equivalent between −6.00 diopters (D) and +0.50 D in both eyes, with an interocular spherical equivalent difference of less than 2.50 D.
Intervention
Participants were randomly assigned in a 1:1 ratio to the intervention group or control group. Participants in the intervention group underwent the home-based VRVT program for 12 weeks. Participants in the control group were observed but received no VRVT intervention. Main Outcome and Measure The primary outcome was the change in distance exotropia control score from baseline to week 12. The Mann-Whitney test and Hodges-Lehmann estimator were used for between-group comparisons. Data analysis followed the modified intention-to-treat approach.
Results
A total of 177 participants (median [IQR] age, 8 [7-10] years; 95 males [53.7%]) were randomized, of whom 161 were included in the full analysis set. At week 12, the median (IQR) change in distance exotropia control score was −0.33 (−1.00 to 0.00) in the intervention group vs 0.00 (−0.33 to 0.33) in the control group (between-group difference, −0.33; 95% CI, −0.57 to −0.10). Participants with greater than 75% VRVT training adherence had a greater improvement in distance exotropia control score than the control group (between-group difference, −0.71; 95% CI, −1.10 to −0.33). A significant interaction was identified between baseline distance exotropia control score and treatment effect ( P for interaction = .01); greater improvement was observed in participants with a baseline score of 2 or higher (between-group difference, −0.67; 95% CI, −1.00 to −0.33), whereas minimal effect was seen in those with a score of 1 (between-group difference, −0.01; 95% CI, −0.23 to 0.20). No intervention-related adverse events were reported. Conclusions and Relevance In this randomized clinical trial, the improvement in distance exotropia control over 12 weeks was modest. However, greater benefits were observed in participants with greater than 75% VRVT training adherence, which may indicate clinical value for children able to maintain high training adherence. Trial Registration Chinese Clinical Trial Registry Identifier: ChiCTR2300072912
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
- Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, Xicheng District, Beijing, China.
- Department of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zitieren
APA
Jing, Y., Li, L., Li, Z., Zhou, T., Zhu, X., Shen, S., Guo, W., Leng, Z., Fan, Y., Guo, K., Zhang, L., Lang, L., Xu, L., Liu, H., & Zhu, H. (2026). Virtual Reality–Based Vision Therapy for Intermittent Exotropia. JAMA Network Open, 9(3), e260631. https://doi.org/10.1001/jamanetworkopen.2026.0631
Vancouver
Jing Y, Li L, Li Z, Zhou T, Zhu X, Shen S, et al. Virtual Reality–Based Vision Therapy for Intermittent Exotropia. JAMA Network Open. 2026;9(3):e260631. doi:10.1001/jamanetworkopen.2026.0631
BibTeX
@article{Jing2026,
author = {Jing, Yu and Li, Li and Li, Zhigang and Zhou, Tiantian and Zhu, Xiaoqi and Shen, Shiya and Guo, Wei and Leng, Zhenhua and Fan, Yunwei and Guo, Kexin and Zhang, Luxi and Lang, Lijuan and Xu, Limin and Liu, Hu and Zhu, Hui},
title = {Virtual Reality–Based Vision Therapy for Intermittent Exotropia},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {3},
pages = {e260631},
doi = {10.1001/jamanetworkopen.2026.0631}
}
EUVIMED